DK160303C - Analogifremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf samt 5'-(2-halogen-4-pyridyl)-1',2',4',-triazol-forbindelser til anvendelse ved fremgangsmaaden - Google Patents
Analogifremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf samt 5'-(2-halogen-4-pyridyl)-1',2',4',-triazol-forbindelser til anvendelse ved fremgangsmaadenInfo
- Publication number
- DK160303C DK160303C DK386882A DK386882A DK160303C DK 160303 C DK160303 C DK 160303C DK 386882 A DK386882 A DK 386882A DK 386882 A DK386882 A DK 386882A DK 160303 C DK160303 C DK 160303C
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- pyrylyle
- halogy
- pyridyl
- analogue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29822481A | 1981-08-31 | 1981-08-31 | |
| US29822481 | 1981-08-31 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK386882A DK386882A (da) | 1983-04-07 |
| DK160303B DK160303B (da) | 1991-02-25 |
| DK160303C true DK160303C (da) | 1991-08-05 |
Family
ID=23149579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK386882A DK160303C (da) | 1981-08-31 | 1982-08-30 | Analogifremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf samt 5'-(2-halogen-4-pyridyl)-1',2',4',-triazol-forbindelser til anvendelse ved fremgangsmaaden |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0074229B1 (da) |
| JP (1) | JPS5846083A (da) |
| KR (1) | KR860000103B1 (da) |
| AR (1) | AR230994A1 (da) |
| AT (1) | ATE19078T1 (da) |
| AU (1) | AU534063B2 (da) |
| CA (1) | CA1177485A (da) |
| DE (1) | DE3270423D1 (da) |
| DK (1) | DK160303C (da) |
| ES (1) | ES515366A0 (da) |
| FI (1) | FI78085C (da) |
| GR (1) | GR77241B (da) |
| HU (1) | HU188328B (da) |
| IE (1) | IE53586B1 (da) |
| IL (1) | IL66673A (da) |
| PH (1) | PH17423A (da) |
| PL (1) | PL134315B1 (da) |
| PT (1) | PT75481A (da) |
| YU (1) | YU42795B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4881725B2 (ja) * | 2003-04-09 | 2012-02-22 | エクセリクシス， インク． | Ｔｉｅ−２モジュレータと使用方法 |
| MX2011011800A (es) | 2009-05-07 | 2012-01-27 | Gruenenthal Gmbh | Derivados de carboxamida y urea aromaticas sustituidas como ligandos del receptor de vanilloides. |
| EP2431035A1 (en) * | 2010-09-16 | 2012-03-21 | Æterna Zentaris GmbH | Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors |
| CA3166630A1 (en) | 2020-01-03 | 2021-07-08 | Berg Llc | Polycyclic amides as ube2k modulators for treating cancer |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4276297A (en) * | 1979-06-18 | 1981-06-30 | Pfizer Inc. | Pyridylaminotriazole therapeutic agents |
-
1982
- 1982-08-25 AR AR290432A patent/AR230994A1/es active
- 1982-08-27 IE IE2087/82A patent/IE53586B1/en unknown
- 1982-08-27 AT AT82304531T patent/ATE19078T1/de active
- 1982-08-27 DE DE8282304531T patent/DE3270423D1/de not_active Expired
- 1982-08-27 GR GR69141A patent/GR77241B/el unknown
- 1982-08-27 EP EP82304531A patent/EP0074229B1/en not_active Expired
- 1982-08-27 CA CA000410270A patent/CA1177485A/en not_active Expired
- 1982-08-30 DK DK386882A patent/DK160303C/da not_active IP Right Cessation
- 1982-08-30 PT PT75481A patent/PT75481A/pt not_active IP Right Cessation
- 1982-08-30 FI FI822999A patent/FI78085C/fi not_active IP Right Cessation
- 1982-08-30 IL IL66673A patent/IL66673A/xx unknown
- 1982-08-30 KR KR8203906A patent/KR860000103B1/ko active
- 1982-08-30 ES ES515366A patent/ES515366A0/es active Granted
- 1982-08-30 AU AU87841/82A patent/AU534063B2/en not_active Ceased
- 1982-08-30 PH PH27793A patent/PH17423A/en unknown
- 1982-08-30 JP JP57150638A patent/JPS5846083A/ja active Pending
- 1982-08-30 HU HU822780A patent/HU188328B/hu unknown
- 1982-08-31 YU YU1963/82A patent/YU42795B/xx unknown
- 1982-08-31 PL PL1982238095A patent/PL134315B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR230994A1 (es) | 1984-08-31 |
| ES8308324A1 (es) | 1983-08-16 |
| IE53586B1 (en) | 1988-12-21 |
| FI822999L (fi) | 1983-03-01 |
| FI78085C (fi) | 1989-06-12 |
| IL66673A (en) | 1986-04-29 |
| AU534063B2 (en) | 1984-01-05 |
| ATE19078T1 (de) | 1986-04-15 |
| EP0074229A1 (en) | 1983-03-16 |
| PH17423A (en) | 1984-08-08 |
| ES515366A0 (es) | 1983-08-16 |
| PL134315B1 (en) | 1985-08-31 |
| IL66673A0 (en) | 1982-12-31 |
| HU188328B (en) | 1986-04-28 |
| FI78085B (fi) | 1989-02-28 |
| KR840001155A (ko) | 1984-03-28 |
| KR860000103B1 (ko) | 1986-02-19 |
| DE3270423D1 (en) | 1986-05-15 |
| YU196382A (en) | 1985-03-20 |
| DK386882A (da) | 1983-04-07 |
| GR77241B (da) | 1984-09-11 |
| AU8784182A (en) | 1983-03-31 |
| FI822999A0 (fi) | 1982-08-30 |
| JPS5846083A (ja) | 1983-03-17 |
| PT75481A (en) | 1982-09-01 |
| PL238095A1 (en) | 1984-03-26 |
| EP0074229B1 (en) | 1986-04-09 |
| YU42795B (en) | 1988-12-31 |
| CA1177485A (en) | 1984-11-06 |
| IE822087L (en) | 1983-02-28 |
| DK160303B (da) | 1991-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK74482A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf samt ved fremgangsmaaden anvendelige udgangsforbindelser | |
| DK153399C (da) | Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf og 4-aminoquinazolin-forbindelser til anvendelse som udgangsmateriale ved fremgangsmaaden | |
| DK490482A (da) | Derivater af cis,endo-2-azabicyclo-(3.3.0)-octan-3-carboxylsyren, fremgangsmaade til deres fremstilling, midler med indhold deraf samt deres anvendelse | |
| DK343388A (da) | 2,2-dimethylchroman-3-ol-derivater og fremgangsmaade til fremstilling deraf, farmaceutiske midler indeholdende derivaterne samt disse anvendelse til fremstilling af farmaceutiske midler | |
| DK190885D0 (da) | 2-(n-substitueret guanidino)-4-heteroarylthiazolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutisk praeparat indeholdende forbindelserne | |
| DK536381A (da) | 8-arylalkyl-3-phenyl-3-nortropanoler eller syreadditionssalte deraf fremgangsmaade til deres fremstilling samt deres anvendelse | |
| DK148537C (da) | Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf | |
| DK65987D0 (da) | 1,4-benzoxazinderivater eller syreadditionssalte deraf, fremgangsmaade til fremstilling af forbindelserne og forbindelsernes anvendelse | |
| DK74382A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf samt ved fremgangsmaaden anvendelige mellemprodukter | |
| DK341281A (da) | Fremgangsmaade til fremstilling af 3,3-dialkyldenzodiazepinderivater eller syreadditionssalte deraf samt ved fremgangsmaaden som mellemprodukter anvendelige forbindelrser | |
| DK157862C (da) | Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK163181C (da) | Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf | |
| DK162842C (da) | Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK284585A (da) | 1,4-dihydropyrinderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse | |
| DK148596C (da) | Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
| DK160303C (da) | Analogifremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf samt 5'-(2-halogen-4-pyridyl)-1',2',4',-triazol-forbindelser til anvendelse ved fremgangsmaaden | |
| DK149854C (da) | Analogifremgangsmaade til fremstilling af 1,2,4-oxadiazolin-5-oner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf samt mellemprodukter til anvendelse ved fremstillingen | |
| DK63582A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf samt ved fremgangsmaaden anvendelige udgangsmaterialer | |
| DK150481C (da) | Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160875C (da) | Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK586284D0 (da) | Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel | |
| DK229090D0 (da) | Mellemprodukter til brug ved fremstilling af 2(2-amino-thiazol-4-yl)glyoxylsyrederivater eller salte deraf og fremgangsmaade til fremstilling af mellemprodukterne | |
| DK151021C (da) | Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK151811C (da) | Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |